Affiliation:
1. Laboratory of Prion Biology and
2. Laboratory of Neurogenomics, Neurobiology Sector, Scuola Internazionale Superiore di Studi Avanzati (SISSA), Trieste;
3. Centro di Referenza per le TSE-Istituto Zooprofilattico Sperimentale del Piemonte Liguria e Valle d'Aosta, Torino; and
4. Italian Institute of Technology, SISSA Unit, Trieste, Italy
Abstract
The conversion of the cellular prion protein (PrPC) to an abnormal and protease-resistant isoform is the key event in prion diseases. Mice lacking PrPCare resistant to prion infection, and downregulation of PrPCduring prion infection prevents neuronal loss and the progression to clinical disease. These results are suggestive of the potential beneficial effect of silencing PrPCduring prion diseases. However, the silencing of a protein that is widely expressed throughout the central nervous system could be detrimental to brain homeostasis. The physiological role of PrPCremains still unclear, but several putative functions (e.g., neuronal development and maintenance) have been proposed. To assess the influence of PrPCon gene expression profile in the mouse brain, we undertook a microarray analysis by using RNA isolated from the hippocampus at two different developmental stages: newborn (4.5-day-old) and adult (3-mo-old) mice, both from wild-type and Prnp0/0animals. Comparing the different datasets allowed us to identify “commonly” co-regulated genes and “uniquely” deregulated genes during postnatal development. The absence of PrPCaffected several biological pathways, the most representative being cell signaling, cell-cell communication and transduction processes, calcium homeostasis, nervous system development, synaptic transmission, and cell adhesion. However, there was only a moderate alteration of the gene expression profile in our animal models. PrPCdeficiency did not lead to a dramatic alteration of gene expression profile and produced moderately altered gene expression levels from young to adult animals. Thus, our results may provide additional support to silencing endogenous PrPClevels as therapeutic approach to prion diseases.
Publisher
American Physiological Society
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献